Search results
Author(s):
Jason Weidman
,
Ramin Mousavi
Added:
1 year ago
Following the announcement of a partnership between Medtronic and CathWorks – firstly concerning the co-promotion of the FFRangio® System, and then a proposed acquisition – hereJason Weidman, Senior Vice President and President of Coronary and Renal Denervation, Medtronic and Ramin Mousavi, CEO, CathWorks, discuss the challenges that have constrained the wider adoption of traditional FFR, and…
View more
Author(s):
Yuhei Kobayashi
Added:
1 year ago
TCT 22 - In this short interview, Dr Yuhei Kobayashi (Albert Einstein College of Medicine, NY, US) joins us to discuss the findings of a substudy of the FAME 3 trial, which aimed to compare FFR-Guided percutaneous coronary Intervention with coronary artery bypass graft surgery (CABG) in a cohort of patients with multivessel CAD.
In this trial, patients with multivessel disease were randomized to…
View more
Author(s):
Andres Vasquez
,
Neville Mistry
,
Jasvindar Singh
Added:
3 years ago
Introduction
Intravascular ultrasound (IVUS) has enhanced our understanding of atherosclerotic plaque morphology, and provides a unique opportunity to guide cardiovascular interventions and evaluate the results of these interventions. IVUS is safe, cost efficient and effective in guiding clinical decisions and cardiovascular interventions and improves outcomes when used during coronary artery…
View more
Author(s):
Eduardo A Arias
,
Félix Damas-de los Santos
,
Heriberto Ontiveros-Mercado
Added:
3 years ago
For more than a decade, studies have sought to address the best treatment strategy for patients with chronic coronary syndromes (CCS), with many suggesting an invasive approach through revascularisation (percutaneous coronary intervention [PCI] or coronary artery bypass grafting [CABG]), and others suggesting a conservative strategy, such as optimal medical therapy (OMT), for this heterogeneous…
View more
Author(s):
David S Wald
,
Jonathan P Bestwick
Added:
3 years ago
The management of patients with acute ST-elevation myocardial infarction (STEMI) relies on restoring blood flow to the occluded infarct artery. Prompt percutaneous coronary intervention (PCI) and stenting of the stenosis causing the occlusion reduces the risk of cardiac death and recurrent infarction.1 In about half of patients,2 stenoses are identified in non-infarct arteries at the time of the…
View more
Author(s):
Bon-Kwon Koo
Added:
2 years ago
In this short interview from our coverage of ACC.22 late-breaking trials, Dr Bon Kwon Koo (Seoul National University Hospital, KR) discusses the FLAVOUR trial (NCT02673424).
FLAVOUR was a multicentre, non-inferiority, randomised clinical trial which sought to compare the safety and efficacy of FFR-guided stenting and IVUS-guided stenting. Presented first at ACC.22, the trial demonstrated that…
View more
Joost Daemen
Research Area(s) / Expertise:
Job title: Interventional Cardiologist
Author
Provisional Stenting Tricks
Author(s):
Francesco Burzotta
,
Carlo Trani
Added:
3 years ago
Article
Author(s):
Suleiman Suleiman
,
JJ Coughlan
,
George Touma
,
et al
Added:
3 years ago
Author(s):
Petr Kala
Added:
3 years ago
Patients suffering acute myocardial infarction with ST-segment elevation (STEMI) require full attention of the whole STEMI network to save their lives and to improve the quality of life after a heart attack. Close cooperation among all stakeholders on a national and regional level has to be established. The emergency medical service (EMS) and direct transportation to the 24 hours a day, seven…
View more